文献速递胰腺与胆道疾病消化道肿瘤与早癌

对接蛋白p130Cas调控胰腺癌发生及胰腺炎中的腺泡-导管化生

Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis.
PubMed 文献 · Gastroenterology · 2021-12-17

研究利用人胰腺导管腺癌(PDAC)样本及多种侵袭性小鼠KrasG12D胰腺癌模型,条件性敲除p130Cas以探究其在Kras诱导肿瘤发生中的作用。结果显示p130Cas在PDAC中高表达且与高组织学分级和不良预后相关;敲除p130Cas可抑制肿瘤发生并显著延长中位生存期,其机制为抑制PI3K-AKT信号,即使在胰腺炎条件下亦然。结论提示p130Cas通过PI3K/AKT通路驱动腺泡-导管化生和肿瘤起始,为高表达p130Cas肿瘤靶向PI3K通路提供依据。

要点

  • p130Cas在PDAC中高表达,与更高组织学分级和不良预后相关。
  • Kras驱动PDAC模型中敲除p130Cas抑制肿瘤发生并显著延长中位生存期。
  • p130Cas通过PI3K-AKT信号促进腺泡-导管化生和肿瘤起始。

核心结论

  • p130Cas作用于Kras下游,增强腺泡-导管化生及后续肿瘤起始所需的PI3K活性。
  • p130Cas通过PI3K/AKT通路对Kras下游发挥驱动作用,提示对高表达p130Cas的肿瘤靶向PI3K通路是合理的治疗策略。

研究设计与样本

  • 使用人PDAC样本及侵袭性递增的鼠KrasG12D依赖性胰腺癌模型。
  • 在胰腺癌模型中对p130Cas进行条件性敲除,以研究其在Kras诱导肿瘤发生中的作用。

主要发现

  • PDAC中常检测到p130Cas高表达,并与更高组织学分级和不良预后相关。
  • 在Kras驱动PDAC模型中,p130Cas缺失抑制肿瘤发展并显著延长中位生存期。
  • p130Cas缺失通过抑制PI3K-AKT信号抑制腺泡来源的肿瘤发生和进展,即使在胰腺炎等恶化条件下亦然。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Acinar to ductal metaplasia is the prerequisite for the initiation of Kras-driven pancreatic ductal adenocarcinoma (PDAC), and candidate genes regulating this process are emerging from genome-wide association studies. The adaptor protein p130Cas emerged as a potential PDAC susceptibility gene and a Kras-synthetic lethal interactor in pancreatic cell lines; however, its role in PDAC development has remained largely unknown. METHODS: Human PDAC samples and murine KrasG12D-dependent pancreatic cancer models of increasing aggressiveness were used. p130Cas was conditionally ablated in pancreatic cancer models to investigate its role during Kras-induced tumorigenesis. RESULTS: We found that high expression of p130Cas is frequently detected in PDAC and correlates with higher histologic grade and poor prognosis. In a model of Kras-driven PDAC, loss of p130Cas inhibits tumor development and potently extends median survival. Deletion of p130Cas suppresses acinar-derived tumorigenesis and progression by means of repressing PI3K-AKT signaling, even in the presence of a worsening condition like pancreatitis. CONCLUSIONS: Our observations finally demonstrated that p130Cas acts downstream of Kras to boost the PI3K activity required for acinar to ductal metaplasia and subsequent tumor initiation. This demonstrates an unexpected driving role of p130Cas downstream of Kras through PI3K/AKT, thus indicating a rational therapeutic strategy of targeting the PI3K pathway in tumors with high expression of p130Cas.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Costamagna A, Natalini D, Camacho Leal MDP, et al. Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis. Gastroenterology. 2021. PMID: 34922945. doi:10.1053/j.gastro.2021.12.242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。